Franklin Resources’s Verona Pharma VRNA Stock Holding History

Franklin Resources’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-127,177	Closed	-$13.6M	–	3281
2025 Q3	$13.6M	Sell	127,177 -1,032,485	-89%	-$108M	﹤0.01%	1076
2025 Q2	$110M	Buy	1,159,662 +146,006	+14%	+$10.8M	0.03%	414
2025 Q1	$64.4M	Buy	1,013,656 +222,552	+28%	+$13.3M	0.02%	529
2024 Q4	$36.7M	Buy	791,104 +231,376	+41%	+$8.69M	0.01%	710
2024 Q3	$19.2M	Buy	+559,728	New	+$13.8M	0.01%	909

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Franklin Resources's VRNA Position: Q4 2025 in Review

Franklin Resources sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 127,177 shares — an estimated $13.6M sold.

Franklin Resources first reported a position in VRNA in Q3 2024 and held it in 5 quarters. The position peaked at $110M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Franklin Resources reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Franklin Resources sold 127,177 Verona Pharma shares in Q4 2025, an estimated $13.6M.
Franklin Resources first reported a position in Verona Pharma in Q3 2024 and held it in 5 quarters.
Franklin Resources's Verona Pharma position peaked at $110M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.